使用精确的Neo2横管甲状腺置换后的导电障碍 横管甲状腺:一种倾向匹配分析
Itamar Loewenstein1, Ariel Finkelstein1, Shmuel Banai1
1Cardiology Department, Tel Aviv Sourasky Medical Center, Israel; Affiliated to Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
概括
与爱德华斯S3和Evolut PRO门相比,ACURATE neo2跨导管大动脉置换 (TAVR) 显示出较低的导电干扰,特别是左束分支阻塞. 这表明使用ACURATE neo2系统的TAVR程序可以获得更好的安全结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- ACURATE neo2跨导管大动脉的设计旨在减少对漏 (PVL) 和保持低率的导电干扰和永久心脏起器植入 (PPMI).
- 上一代跨导管大动脉置换器 (TAVR) 显示出这些并发症的发生率不同.
研究的目的:
- 为了比较ACURATE neo2门和其他常用的TAVR门之间的传导干扰和PVL的速率.
- 评估与ACURATE neo2 TAVR相关的程序结果.
主要方法:
- 对以色列TAVR注册表 (2014-2023) 进行了回顾性分析.
- 患者接受ACURATE neo2,Edwards Sapien 3 (S3) 和Evolut PRO门进行了比较.
- 使用倾向性得分匹配来确保组之间可比的患者特征.
主要成果:
- 分析包括3208名患者,每组为169名的倾向匹配组.
- 与S3 (37.5%) 和Evolut PRO (27.5%) 相比,ACURATE neo2的导电干扰率明显较低 (15.8%).
- 在ACURATE neo2 (9.0%) 与S3 (31.3%) 和Evolut PRO (20.1%) 相比,左捆分支区块 (LBBB) 的较低率被观察到.
结论:
- 与Evolut PRO和Edwards S3相比,用ACURATE neo2进行过导管大动脉置换与较低的导电干扰复合率有关.
- 导电干扰的减少主要是由LBBB的较低率驱动的.
- 永久心脏起器植入 (PPMI) 和副漏 (PVL) 的发生率与ACURATE neo2.2无关显著较低.
相关概念视频
Mitral Stenosis II: Clinical features and Diagnostic Tests
557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
1.2K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495


